PMID: 3384428Apr 1, 1988Paper

Recurrent vaginal candidosis: prospective study of effectiveness of maintenance miconazole treatment

Genitourinary Medicine
M J Balsdon, J M Tobin

Abstract

In a prospective study, 100 women with recurrent vaginal candidosis were treated with miconazole, using two 100 mg vaginal pessaries a day for one week, then one pessary twice a week for three months followed by one pessary a week for a further three months. Fifty four women elected to continue using one pessary a week for longer than six months. Symptomatic vaginal candidosis did not occur in any patient during regular maintenance treatment. Of the 46 women who discontinued treatment before six months, however, 22 had a recurrence. Maintenance prophylactic treatment with miconazole pessaries appears to be an acceptable and effective method of preventing recurrent episodes of vaginal candidosis.

References

Jun 1, 1978·The British Journal of Venereal Diseases·F Davidson, R F Mould
Apr 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·K J SmithH Vanden Bossche
Feb 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·J F Ryley

❮ Previous
Next ❯

Citations

Dec 14, 1990·Pharmaceutisch Weekblad. Scientific Edition·A J Roex
Apr 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A M van Heusden, J M Merkus
Apr 1, 1991·Genitourinary Medicine·S RashidR J Kennedy
Jul 15, 2015·American Journal of Obstetrics and Gynecology·Jack D Sobel
Sep 1, 1990·Journal of the American Academy of Dermatology·J D Sobel
Oct 1, 1996·The Annals of Pharmacotherapy·G E SteinS L Schooley
Oct 1, 2016·Mycoses·Gilbert G G Donders, Jack D Sobel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.